deferoxamine mesylate
Generic: deferoxamine mesylate
Labeler: gland pharma limitedDrug Facts
Product Profile
Brand Name
deferoxamine mesylate
Generic Name
deferoxamine mesylate
Labeler
gland pharma limited
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
deferoxamine mesylate 2 g/1
Manufacturer
Identifiers & Regulatory
Product NDC
68083-173
Product ID
68083-173_316b7751-fbd4-4b19-b7b7-701554fd3b21
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207384
Listing Expiration
2026-12-31
Marketing Start
2017-10-09
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68083173
Hyphenated Format
68083-173
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
deferoxamine mesylate (source: ndc)
Generic Name
deferoxamine mesylate (source: ndc)
Application Number
ANDA207384 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 g/1
Packaging
- 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68083-173-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "316b7751-fbd4-4b19-b7b7-701554fd3b21", "openfda": {"unii": ["V9TKO7EO6K"], "rxcui": ["1731345", "1731350"], "spl_set_id": ["598fba68-f46e-4b6e-894c-63c2940b2063"], "manufacturer_name": ["Gland Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68083-173-01)", "package_ndc": "68083-173-01", "marketing_start_date": "20171009"}], "brand_name": "Deferoxamine mesylate", "product_id": "68083-173_316b7751-fbd4-4b19-b7b7-701554fd3b21", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "68083-173", "generic_name": "Deferoxamine mesylate", "labeler_name": "Gland Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferoxamine mesylate", "active_ingredients": [{"name": "DEFEROXAMINE MESYLATE", "strength": "2 g/1"}], "application_number": "ANDA207384", "marketing_category": "ANDA", "marketing_start_date": "20171009", "listing_expiration_date": "20261231"}